Amin Sayyadi

Dr. Amin Sayyadi

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2024 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
GYGholamreza Yousefzadeh
Gholamreza Yousefzadeh
ASAmin Sayyadi
Amin Sayyadi
HNHamid Najafipour
Hamid Najafipour
VSVida Sabaghnejad
Vida Sabaghnejad
SPSara Pezeshki
Sara Pezeshki
Introduction: Atherosclerotic cardiovascular diseases (ASCVD) are significant sources of mortality and morbidity with substantial economic implications and preventive measures play key roles in this regard. Metabolic syndrome (MetS) is a common condition, and its association with ASCVD and mortality has made it clinically important. However, controversies persist regarding the best definition for MetS. Here in, we investigated the ability of the International Diabetes Federation (IDF) and the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) in the prediction of ASCVD incidence.Methods: We conducted an investigation on individuals diagnosed with MetS as part of the “Kerman Coronary Artery Diseases Risk Factor Study” (KERCADRS). This study was a cohort study conducted on a population aged 15–75 years residing in Kerman, Iran to assess the risk of ASCVD. We employed ACC/AHA ASCVD Risk Estimator for predicting ASCVD occurrence in the future and then compared the results with different definitions of MetS including IDF and NCEP ATP III.Results: Patients with MetS consistent with NCEP ATP III had higher ASCVD risk scores than those with IDF (10.63 ± 10.989 vs. 9.50 ± 9.357). NCEP ATP III had better overall performance in terms of specificity, accuracy, sensitivity and positive and negative predictive values especially in higher ASCVD risk score categories. The agreement between IDF and NCEP ATP III was none to slight (Cohen's Kappa 30%, which revealed no agreement (Cohen's Kappa = 0).Conclusion: NCEP ATP III has better overall performance compared to IDF. The ability of NCEP ATP III increases as the ASCVD risk score goes higher. IDF may be useful in primary screening and patients with lower ASCVD risk scores.

2 July 2023 in Rheumatology
Verified
Journal Article
Open access
AHAli Hosseininasab
Ali Hosseininasab
FPFahime Pashang
Fahime Pashang
MRMohammad Rezaei Zadeh Rukerf
Mohammad Rezaei Zadeh Rukerf
HMHanieh Mirkamali
Hanieh Mirkamali
MNMohsen Nakhaie
Mohsen Nakhaie
ASAmin Sayyadi
Amin Sayyadi
Introduction: Kawasaki disease (KD) is a systemic vasculitis, seen mostly in children. Epidemiology of KD is dependent on geographical location and seasonality. Although many years have passed since the first report of KD, multiple related factors are still unknown. Material and methods: We...

7 March 2023 in Clinical Case Reports
Verified
Journal Article
Open access
ASAmin Sayyadi
Amin Sayyadi
MMMahsa Mahdavi
Mahsa Mahdavi
BDBehnam Dalfardi
Behnam Dalfardi
FRFatemeh Karami Robati
Fatemeh Karami Robati
MSMohsen Shafiepour
Mohsen Shafiepour
A young lady with a history of infertility presented to the hospital with dyspnea and chest pain a few days after ovulation induction. Her manifestations were consistent with ovarian hyperstimulation syndrome (OHSS). Further investigations revealed right atrial thrombus and pulmonary thromboembolism. We successfully managed the condition with conservative therapy.

4 July 2023 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
ASAmin Sayyadi
Amin Sayyadi
MMMohammad Mehdi Maleksaabet
Mohammad Mehdi Maleksaabet
MGMohammad Hossein Gozashti
Mohammad Hossein Gozashti
Introduction: Diabetes is a disease with high prevalence and causes heavy economic burden. Mental and physical health are tied together and their interaction determines one's health or sickness. Early maladaptive schemas (EMSs) are suitable indicators of mental health. We investigated the association between EMSs and glycaemic control in type 2 diabetes mellitus (T2DM) patients.Methods: We conducted a cross‐sectional study in 2021 on 150 patients with T2DM. We used two questionnaires a demographic data questionnaire, and a Young Schema Questionnaire 2 – Short Form for gathering the data. We also performed laboratory tests on our participants and used the results of fasting blood sugar and haemoglobin A1c to evaluate glycaemic control.Results: Most of our participants were females (66%). Most of our patients were 41–60 years old (54%). There were only three single participants, and 86.6% of our individuals did not have a university degree. Total mean ± SD for EMSs score was 192.45 ± 55.66; self‐sacrifice (19.09 ± 4.64) and defectiveness/shame (8.72 ± 4.45) had the highest and lowest EMSs scores, respectively. None of the demographic data had any significant impact on EMSs scores or glycaemic control, but generally, younger patients with higher levels of education had better glycaemic control. Participants with higher scores for defectiveness/shame and insufficient self‐control had significantly worse glycaemic control.Conclusion: Mental and physical health are tied together, and paying attention to psychological aspects in prevention and management of physical disorders is crucial. EMSs, especially defectiveness/shame and insufficient self‐control are associated with glycaemic control of T2DM patients.

6 July 2024 in Heliyon
Verified
Journal Article
Open access
ASAmin Sayyadi
Amin Sayyadi
FSFaranak Salajegheh
Faranak Salajegheh
BDBehnam Dalfardi
Behnam Dalfardi
MSMohsen Shafiepour
Mohsen Shafiepour
Mucormycosis can be lethal in people with immunocompromising conditions, especially Diabetes Mellitus. Correction of the underlying disorders, instant initiation of antifungal therapy, and surgical resection are the main components of treatment. Herin, we present the successful medical management of Mucormycosis in a patient with Diabetic Ketoacidosis and positive SARS-CoV-2 test who presented with a less seen condition: the simultaneity of mediastinal mass on one side and an endobronchial mass on the other. An 18-year-old male with a history of insulin-dependent DM from 4 years ago presented to our hospital with sudden onset dyspnea, chest pain, sore throat, hoarseness, cough, and sputum. Also, we detected unilateral swelling in the neck and multiple lymph nodes in the neck. Lung auscultation revealed bilateral generalized wheezing. Primary laboratory tests detected high blood sugar, metabolic acidosis, positive urine ketone, high ESR, positive CRP, and leukocytosis; his polymerase chain reaction (PCR) for SARS-CoV-2 was positive. Chest X-ray showed left upper lobe consolidation. Computed tomography scan (CT-scan) of the chest revealed a large collapse consolidation in the left lung, mild left side pleural effusion, mediastinal lymphadenopathy, and distention in the esophagus. With suspicion of malignancy, we performed flexible bronchoscopy and endobronchial Ultrasound (EBUS) which revealed a creamy tumoral lesion in the right main bronchus. The biopsy was consistent with Mucormycosis. We successfully treated Mucormycosis with Amphotericin-B liposomal. Mucormycosis can mimic the clinical characteristics of malignancy, and emphasize the importance of considering appropriate differential diagnoses because timely diagnosis and treatment is potentially life-saving in Mucormycosis.

19 April 2024 in Brain and Behavior
Verified
Journal Article
Open access
LJLeila Sadat Mohamadi Jahromi
Leila Sadat Mohamadi Jahromi
ASAmin Sayyadi
Amin Sayyadi
AAAida Askarian
Aida Askarian
ADAlireza Dabbaghmanesh
Alireza Dabbaghmanesh
SRSharareh Roshanzamir
Sharareh Roshanzamir
Introduction: Generalized joint hypermobility (GJH) can be the result of several hereditary connective tissue disorders, especially Ehlers–Danlos syndrome. Cerebrovascular manifestations are among the most common complications in this disorder, and understanding their extent can help better diagnosis and prevention of hazardous events. We investigated visual evoked potential (VEP) changes in patients with GJH and compared them with healthy individuals.Methods: Our case–control study included 90 patients who fulfilled the Beighton score (B score) for joint hypermobility and other 90 healthy participants. All of them went under VEP study, and the amplitude and latency of the evoked potential (P100) were compared to each other.Results: The Case group had significantly higher B score (7.18 ± 0.967 vs. 1.18 ± 0.712), P100 latency (110.23 ± 6.64 ms vs. 100.18 ± 4.273 ms), and amplitude (6.54 ± 1.26 mv vs. 6.50 ± 1.29 mv) compared with the Control group, but the difference was only significant regarding B score, and P100 latency (p‐value <.0001). Moreover, both latency and amplitude of P100 had significantly positive correlations with the B score in the Case group (p‐value <.0001), but such correlations were not found in the Control group (p‐value = .059).Conclusion: Our study could reveal VEP changes, especially significant P100 latency in GJH patients without previous neurologic or musculoskeletal disorders. Whether these changes are due to GJH itself or are predictive of inevitable neurologic disease or visual pathway involvement, particularly Multiple Sclerosis needs further investigation with longer follow‐up periods.